Serum immune checkpoint profiling identifies soluble CD40 as a biomarker for pancreatic cancer.
Digomann D, Heiduk M, Reiche C, Glück J, Kahlert C, Mirtschink P, Klimova A, Bösch F, Tonn T, Gaedcke J, Ghadimi M, Weitz J, Seifert L, Seifert AM.
Digomann D, et al. Among authors: gluck j.
NPJ Precis Oncol. 2023 Oct 14;7(1):104. doi: 10.1038/s41698-023-00459-9.
NPJ Precis Oncol. 2023.
PMID: 37838778
Free PMC article.